Cure Ventures backs a cell therapy startup targeting Parkinson's
BioPharma
Source: biopharmadive.com
📰 Column Group News
Page 2 - Column Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Column Group. Real-time updates on events, politics, business and more.
Kenai Therapeutics Announces 82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases
Kenai Therapeutics a biotechnology company leveraging induced pluripotent stem cell iPSC technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders today announced an 82 million Series A financing coled by Alaska Permanent Fund Corporation Cure Ventures and The Column Group with participation from Euclidean Capital and Saisei Ventures.
Source: businesswireindia.com
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - AA, NGM, MDC, KAMN -February 26, 2024 at 07:45 pm EST
NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Monteverde & Associates PC , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services...
Source: marketscreener.com
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates NGM, AA, HRT, KNTE
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Source: prnewswire.com
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates NGM, AA, HRT, KNTE -February 26, 2024 at 10:16 pm EST
NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Zachary Halper Daniel Sadeh Biopharmaceuticals Inc Alumina Limited Prnewswire Halper Sadeh Biopharma Inc
Source: marketscreener.com
NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM -February 27, 2024 at 04:11 pm EST
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of NGM Biopharmaceuticals, Inc. to affiliates of The...
Source: marketscreener.com
Neurona Therapeutics Raises $120M in Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders
SAN FRANCISCO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell ther...
Source: businessinsider.com
Tenaya Therapeutics Shares Rise 25% After Offering Prices
By Chris Wack Tenaya Therapeutics shares were up 25% at $5.54 after the company priced its underwritten offering of 8.9 million shares at $4.50 a share. The...
Chris Wack Column Group Venrock Healthcare Capital Article Normal Biotechnology Services Trusts Funds Financial Vehicles
Source: marketwatch.com